| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Alan J Russell is Chief Scientific Officer at EWTX. From September 2021 to August 2026, the filings on record show 0 open-market purchases and 23 sales. Alan J Russell's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.2M at current prices.
Historically, Alan J Russell's trades have earned a strong insider score of 74/100 across 38 rated trades. Over a 12-month horizon, 83.3% of those trades were profitable, with an average 12-month return of +20.8%.
The EWTX filings lean toward selling, a net 1,033,637 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 2, 2024 | EWTX Edgewise Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,576 | $18.91 | $29,802.16 | -17.9% | -11.7% | -12.3% | |
| Dec 26, 2023 | EWTX Edgewise Therapeutics, Inc. | Chief Scientific Officer | Sell | 172,585 | $9.33 | $1,610,097.24 | -98.0% | +68.1% | +211.6% | |
| May 2, 2023 | EWTX Edgewise Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,602 | $8.90 | $14,265.65 | -0.9% | -16.7% | +117.3% | |
| Nov 15, 2021 | EWTX Edgewise Therapeutics, Inc. | Chief Scientific Officer | Sell | 479 | $19.11 | $9,155.40 | -100% | -41.5% | -46.5% | |
| Nov 12, 2021 | EWTX Edgewise Therapeutics, Inc. | Chief Scientific Officer | Sell | 69,740 | $19.91 | $1,388,787.60 | -99.3% | -34.5% | -44.2% | |
| Nov 8, 2021 | EWTX Edgewise Therapeutics, Inc. | Chief Scientific Officer | Sell | 29,451 | $19.82 | $583,823.46 | -29.5% | -37.7% | -52.2% | |
| Nov 3, 2021 | EWTX Edgewise Therapeutics, Inc. | Chief Scientific Officer | Sell | 44,172 | $17.88 | $789,908.90 | -30.7% | -28.9% | -47.9% | |
| Oct 15, 2021 | EWTX Edgewise Therapeutics, Inc. | Chief Scientific Officer | Sell | 7,182 | $18.17 | $130,482.95 | -4.8% | -2.7% | -41.3% | |
| Oct 11, 2021 | EWTX Edgewise Therapeutics, Inc. | Chief Scientific Officer | Sell | 1,270 | $18.02 | $22,885.40 | -0.8% | +6.5% | -40.6% | |
| Oct 8, 2021 | EWTX Edgewise Therapeutics, Inc. | Chief Scientific Officer | Sell | 21,028 | $18.39 | $386,742.62 | -12.1% | -0.7% | -45.6% |